Globe Newswire
Des Moines, IA, June 03, 2024 (GLOBE NEWSWIRE) -- LCS has announced the finalists for the 2024 LCS “Chef of the Year” competition. The annual competition celebrates the hospitality and culinary talents of chefs in senior living communities owned and managed by Life Care Services. Chef of the Year finalists were selected by a steering committee that reviewed applicant recipes, plated dishes, and videos highlighting work in their respective communities.
Five... (continue reading...)
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1)State Street Global Advisors & AffiliatesCompany dealt inIrish Residential Properties REIT plcClass of... (continue reading...)The trial will be conducted in the U.S. and its results will complement the preclinical data on the LIBERTY® Endovascular Robotic Surgical System, which together are expected to support a future 510(k) submission
BRAINTREE, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announces that it has received the U.S. Food and Drug Administration’s (“FDA”)... (continue reading...)
Company announcementfor ROCKWOOL A/SRelease no. 30 – 2024to Nasdaq Copenhagen
3 June 2024
Report on transactions of executives and related parties in ROCKWOOL A/S shares
ROCKWOOL A/S has received and hereby provides notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in ROCKWOOL A/S made by persons discharging managerial responsibilities and/or persons closely related with them.
1 Details... (continue reading...)
Company plans to release topline results from “lead-in” patients (n=5) imminently
THE WOODLANDS, TX, June 03, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced it has received Ethics Committee approval of the protocol amendment for its... (continue reading...)
More Globe Newswire
View Older Stories-
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
-
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
-
Molecular Templates, Inc. Provides Interim Update
-
Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution for Unmanned Aircraft Systems
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 31 05 2024] - (CGWL)
-
Coherent Appoints Jim Anderson as Chief Executive Officer
-
Four Charlesbank Portfolio Companies Named to Newsweek’s “America’s Greatest Workplaces for Mental Wellbeing 2024”
-
NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024
-
InnovAge PACE Recertified as a Great Place to Work
-
Noom Launches Noom Vibe, a Wellness Community and Habit Tracker Built for the Age of GLP-1s
-
Ready Capital to Present at Nareit’s REITweek 2024
-
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference
-
AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY
-
Texas Must Close Primary Elections
-
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp When Compared to a Matched External Control Arm at the 2024 ASCO Annual Meeti
-
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
-
Genesis Offers New Tools and Incentives to Financial Industry Software Developers
-
Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies
-
BriaCell Presents Clinical Efficacy Data at ASCO 2024
-
Tonix Pharmaceuticals Presented New Data on Tonmya™ Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual Meeting
-
Entera Bio Reports Phase 1 Clinical Data of First-in-Class, Oral PTH(1-34) Peptide Candidate (EB612) for Patients with Hypoparathyroidism at ENDO 2024
-
PetMed Express, Inc. Announces Strategic Updates to Executive Leadership Team
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
Enphase Energy Launches IQ Battery 5P in Canada
-
KULR Announces Expiration of SEPA Facility and Compliance with NYSE Guidelines on Audit Opinion Disclosure
-
Apogee Minerals Announces Appointment of New Director
-
ASP Isotopes Inc. Receives Purchase Order from a Leading Global Industrial Gases Company for the Supply of Highly Enriched Electronic Gases
-
ORYZON Announces Journal Publication of Final Phase IIa ALICE Results with Iadademstat in The Lancet Hematology
-
Abacus Life and AIMCOR Announce New National Distribution Agreement
-
Replimune Presents Positive Data from RP1 and RP2 Clinical Programs at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Gabelli Funds to Host 16th Annual Media & Entertainment Symposium Thursday, June 6, 2024
-
Core Molding Technologies to Present and Host 1x1 Meetings at the 14th Annual East Coast IDEAS Conference on June 13, 2024
-
Arcutis to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
-
Mineralys Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
-
ConnectWise Research finds 78% of SMBs Concerned a Cyber Attack Could Put Their Organizations Out of Business
-
Introducing the TimeProvider® XT Extension System for Migrating to a Modern Synchronization and Timing Systems Architecture
-
DZS Completes NetComm Acquisition
-
ASP Isotopes Inc. Receives Purchase Order from a Leading Global Industrial Gases Company for the Supply of Highly Enriched Electronic Gases
-
European Cup Inu: Transforming the Euro 2024 Experience with Innovative Crypto Betting
-
Syntec Optics (Nasdaq: OPTX) to Participate in the “Charting the Course: Navigating the Intersection of TMT and Business in the AI Era” Conference
-
Cyclacel Pharmaceuticals Reports New Clinical Data at 2024 ASCO Annual Meeting Highlighting Oral Fadraciclib’s Potential as a Precision Medicine for Cancer
-
VCI Global Gives Full Year Guidance After Seeing Revenues Increase Over 145% in 2023
-
LiveOne to Host Special Investor Webcast to Provide Update on Strategic Partnerships, B2B Pipeline and Addressable Market for all Subsidiaries
-
The Metals Company Welcomes Prominent Sustainability Strategist Brendan May to its Board of Directors
-
FangDD Announces Termination Plan for Its ADR Facility, and the Plan to Hold an Extraordinary General Meeting of Shareholders
-
Scorpius Holdings and Beyond Imagination Announce Trailblazing Partnership to Utilize Autonomous AI-Powered Humanoid Robots for American Biomanufacturing
-
Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing’s Syndrome)
-
Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities
-
Getty Realty Corp. Publishes 2024 Corporate Responsibility Report
-
23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting